New medicines generate €52bn in socioeconomic value
New medicines for cancer, heart diseases and respiratory diseases are expected to generate almost €52 billion in socioeconomic value for Ireland over a 20 year period, according to a new study by the WifOR Economic Research Institute for the Irish Pharmaceutical Healthcare Association (IPHA).